However, EGFR HS values were higher than KRAS HS values, possibly because the concurrence of EGFR amplification and mutations occur frequently in patients with lung adenocarcinoma, as we previously described (Shan et al., 2015). The gene discussed is KRAS; the disease is lung adenocarcinoma.